GHP Investment Advisors »

Anika Therapeutics shares owned by GHP Investment Advisors

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by GHP Investment Advisors from 13F filings

Historical chart of GHP Investment Advisors investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by GHP Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by GHP Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $638 44 14.50

More positions owned by GHP Investment Advisors

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Intl Sel Div Etf (IDV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr Series Trust State Street Spd (MDYG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Fundamental Intl (FNDC)
Franklin Templeton Etf Tr Ftse Untd Kgdm (FLGB)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ESCO Technologies (ESE)

View all positions for GHP Investment Advisors

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Morgan Stanley
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Boothbay Fund Management
Renaissance Technologies
Dimensional Fund Advisors
Capital Management Corporation
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics